Axxcess Wealth Management LLC Has $309,000 Stock Position in Aflac Incorporated (NYSE:AFL)

Axxcess Wealth Management LLC trimmed its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 51.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,988 shares of the financial services provider's stock after selling 3,155 shares during the period. Axxcess Wealth Management LLC's holdings in Aflac were worth $309,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new stake in shares of Aflac during the 4th quarter worth about $163,409,000. Amundi increased its stake in shares of Aflac by 81.1% during the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider's stock valued at $285,181,000 after acquiring an additional 1,232,683 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in Aflac by 471.4% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 600,000 shares of the financial services provider's stock worth $67,080,000 after purchasing an additional 495,000 shares in the last quarter. Assenagon Asset Management S.A. lifted its position in Aflac by 670.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider's stock worth $57,572,000 after purchasing an additional 484,378 shares during the period. Finally, World Investment Advisors LLC bought a new position in Aflac during the 3rd quarter valued at $42,290,000. Institutional investors own 67.44% of the company's stock.

Aflac Stock Up 0.6 %

AFL stock traded up $0.68 during midday trading on Wednesday, reaching $110.41. The company had a trading volume of 1,357,781 shares, compared to its average volume of 1,991,370. The company has a 50 day moving average of $106.21 and a two-hundred day moving average of $107.62. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 1 year low of $79.31 and a 1 year high of $115.50. The company has a market capitalization of $60.35 billion, a P/E ratio of 11.50, a PEG ratio of 3.24 and a beta of 0.93.

Remove Ads

Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, equities research analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. BMO Capital Markets started coverage on Aflac in a report on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 price objective for the company. Keefe, Bruyette & Woods cut their price target on shares of Aflac from $107.00 to $104.00 and set a "market perform" rating for the company in a report on Wednesday, February 12th. Barclays reduced their price objective on shares of Aflac from $98.00 to $95.00 and set an "underweight" rating for the company in a research report on Friday, February 7th. Piper Sandler dropped their target price on shares of Aflac from $122.00 to $118.00 and set an "overweight" rating on the stock in a report on Friday, February 7th. Finally, Morgan Stanley raised their target price on shares of Aflac from $98.00 to $105.00 and gave the stock an "equal weight" rating in a report on Friday, February 28th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, Aflac has an average rating of "Hold" and a consensus price target of $103.36.

Insider Activity at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the sale, the director now owns 25,393 shares of the company's stock, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 55,546 shares of company stock valued at $5,863,616. 0.90% of the stock is owned by corporate insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.